SPIA
CORT icon

Steward Partners Investment Advisory’s Corcept Therapeutics CORT Stock Holding History

Steward Partners Investment Advisory’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.4K Sell
706
-9,000
-93% -$543K ﹤0.01% 2830
2026
Q1 		$391K Hold
9,706
– – ﹤0.01% 1649
2025
Q4 		$338K Sell
9,706
-415
-4% -$32.6K ﹤0.01% 1647
2025
Q3 		$841K Hold
10,121
– – ﹤0.01% 1122
2025
Q2 		$743K Sell
10,121
-991
-9% -$71.8K 0.01% 1119
2025
Q1 		$1.27M Sell
11,112
-1,138
-9% -$69.3K 0.01% 818
2024
Q4 		$617K Buy
12,250
+138
+1% +$7.23K 0.01% 1066
2024
Q3 		$561K Sell
12,112
-12,592
-51% -$447K 0.01% 1062
2024
Q2 		$803K Buy
24,704
+3,490
+16% +$95.6K 0.01% 883
2024
Q1 		$534K Buy
+21,214
New +$501K 0.01% 1032
2023
Q4 		– Sell
-2,853
Closed -$77.7K – 3500
2023
Q3 		$77.7K Buy
+2,853
New +$82.6K ﹤0.01% 1696
2021
Q4 		– Sell
-30
Closed -$1K – 3199
2021
Q3 		$1K Buy
+30
New +$628 ﹤0.01% 3056
2021
Q1 		– Sell
-800
Closed -$21K – 3427
2020
Q4 		$21K Hold
800
– – ﹤0.01% 2028
2020
Q3 		$14K Buy
+800
New +$12.7K ﹤0.01% 2007
2020
Q1 		– Sell
-2
Closed – – 2520
2019
Q4 		$0 Sell
2
-74
-97% -$1.03K ﹤0.01% 2600
2019
Q3 		$1K Buy
76
+73
+2,433% +$897 ﹤0.01% 2506
2019
Q2 		$0 Buy
+3
New +$33 ﹤0.01% 2615

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steward Partners Investment Advisory's CORT Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Corcept Therapeutics (CORT) stake by 93% in Q2 2026, selling an estimated $543K and leaving 706 shares worth $61.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2830.

Steward Partners Investment Advisory first reported a position in CORT in Q2 2019 and has held it in 17 quarters since. The position peaked at $1.27M in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Steward Partners Investment Advisory held 706 shares of Corcept Therapeutics worth $61.4K as of Q2 2026.
  • Steward Partners Investment Advisory sold 9,000 Corcept Therapeutics shares in Q2 2026, an estimated $543K.
  • Corcept Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2830 holding.
  • Steward Partners Investment Advisory first reported a position in Corcept Therapeutics in Q2 2019 and has held it in 17 quarters since.
  • Steward Partners Investment Advisory's Corcept Therapeutics position peaked at $1.27M in Q1 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.